Acer Medical, Inc. provides technology solutions based on artificial intelligence (AI) and big data to medical facilities and other medical industries. Its products include VeriSeeDR that diagnoses retina diseases related to diabetes based on AI, and TeleMed that facilitates online doctor consulting. The company was founded on April, 25, 2018 and is headquartered in New Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company